ducovest

L0T:F:F-GE HEALTHCARE TECH.INC. (EUR)

COMMON STOCK | Health Information Services |

Last Closing

USD 80.85

Change

0.00 (0.00)%

Market Cap

USD 37.77B

Volume

4.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Company Website : https://www.gehealthcare.com

Currency: EUR

Country : Germany

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-03 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
2HE:F Healthequity Inc

N/A

 USD 6.90B
4YC:F M3 INC.

N/A

 USD 6.89B
6HL0:F R1 RCM Inc

N/A

 USD 5.57B
9EH:F Evolent Health Inc

N/A

 USD 2.44B
OC9:F Omnicell Inc

N/A

 USD 2.04B
1KJ:F 10X GENOMICS DL -00001

N/A

 USD 1.73B
6JM:F JMDC INC.

N/A

 USD 1.69B
1XZ:F Ping An Healthcare and Technol..

N/A

 USD 1.55B
4LL:F Teladoc Inc

N/A

 USD 1.50B
19P:F Phreesia Inc

N/A

 USD 0.98B

ETFs Containing L0T:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.33% 73% C 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.33% 73% C 71% C-
Trailing 12 Months  
Capital Gain 24.38% 76% C+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.38% 76% C+ 69% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.77% 76% C+ 58% F
Dividend Return 5.81% 73% C 52% F
Total Return 0.03% 8% B- 2% F
Risk Return Profile  
Volatility (Standard Deviation) 10.12% 92% A 89% A-
Risk Adjusted Return 57.35% 92% A 73% C
Market Capitalization 37.77B 100% F 95% A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.